ScaiVision® v1.0.0 was released internally and benchmarked in a massive experiment, outperforming all competitor algorithms.
Scailyte™ and ScaiVision™ are registered trademarks proprietary to Scailyte AG.
Recent News
ScaiVision® performs best-in-class at sample class prediction!
ScaiVision® v1.0.0 was released internally and benchmarked in a massive experiment, outperforming a
Recent News
Scailyte participates @ swissnex san francisco DEMO DAY!
Striving to internationalize and network, Scailyte participates and pitches at the swissnex Demo Day
Recent News
Scailyte Q3 2020 Update
Q3 2020 update on Scailyte's progress towards its mission to save millions of lives.
Recent News
ETH Industry E-Week 2020 features Scailyte with the headline: Using Artificial Intelligence to unlock the clinical potential of single-cell data.
As ETH- Spin-off Scailyte attends the 2020 Industry eWeek giving updates on the disease area focus,
Recent News
Recent News
Interview with Scailyte’s CEO Peter Nestorov
In the interview done by Venturelab, Peter talks about the challenges of an entrepreneur. As the CEO
Recent News
Interview with Scailyte Founder Prof. Dr. Manfred Claassen
In an interview with Investiere our founder and scientific advisor Prof. Dr. Manfred Claassen descri
Recent News
Scailyte: simplifying difficult diagnoses
Making a diagnosis can be a tricky endeavour. For instance, diagnosing skin T-cell lymphoma, a rare
Recent News
ScaiVision® performs best-in-class at sample class prediction!
ScaiVision® v1.0.0 was released internally and benchmarked in a massive experiment, outperforming a
Scailyte participates @ swissnex san francisco DEMO DAY!
Striving to internationalize and network, Scailyte participates and pitches at the swissnex Demo Day
Recent News
Scailyte Q3 2020 Update
Q3 2020 update on Scailyte's progress towards its mission to save millions of lives.
ETH Industry E-Week 2020 features Scailyte with the headline: Using Artificial Intelligence to unlock the clinical potential of single-cell data.
As ETH- Spin-off Scailyte attends the 2020 Industry eWeek giving updates on the disease area focus,
Recent News
Interview with Scailyte’s CEO Peter Nestorov
In the interview done by Venturelab, Peter talks about the challenges of an entrepreneur. As the CEO
Recent News
Interview with Scailyte Founder Prof. Dr. Manfred Claassen
In an interview with Investiere our founder and scientific advisor Prof. Dr. Manfred Claassen descri
Scailyte: simplifying difficult diagnoses
Making a diagnosis can be a tricky endeavour. For instance, diagnosing skin T-cell lymphoma, a rare